CD44 and neoplasm: The extracellular region of CD44 binding to ligands has been found to involve various of signaling pathways associated with physiological and pathological processes,7, 8 in particular, pathways related to carcinogenesis and tumor progression including proliferation and migration of cells, drug resistance, as well as epithelial–mesenchymal transition (EMT).9, 10, 11